ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,353,594 | +126.2% | 1,468,544 | +192.7% | 0.21% | +22.6% |
| Q2 2023 | $23,146,742 | -42.1% | 501,772 | -49.7% | 0.17% | -4.0% |
| Q1 2023 | $39,973,204 | +52.4% | 996,838 | +76.1% | 0.18% | -34.7% |
| Q4 2022 | $26,222,780 | +86.3% | 566,000 | +66.5% | 0.27% | +114.4% |
| Q3 2022 | $14,079,000 | +159.3% | 340,000 | +273.6% | 0.12% | +204.9% |
| Q2 2022 | $5,429,000 | +120.2% | 91,000 | +203.3% | 0.04% | +10.8% |
| Q3 2020 | $2,466,000 | -76.6% | 30,000 | -77.8% | 0.04% | -80.0% |
| Q2 2020 | $10,559,000 | +1.7% | 135,000 | -42.2% | 0.18% | -28.8% |
| Q1 2020 | $10,384,000 | -16.2% | 233,706 | -19.4% | 0.26% | -5.8% |
| Q4 2019 | $12,386,000 | +86.8% | 290,000 | +87.1% | 0.28% | +50.8% |
| Q3 2019 | $6,631,000 | -5.1% | 155,000 | +40.9% | 0.18% | +14.4% |
| Q2 2019 | $6,985,000 | -8.5% | 110,000 | 0.0% | 0.16% | +63.3% |
| Q1 2019 | $7,630,000 | +75.5% | 110,000 | +10.0% | 0.10% | +69.0% |
| Q4 2018 | $4,348,000 | -28.9% | 100,000 | -16.7% | 0.06% | -54.3% |
| Q1 2018 | $6,119,000 | +31.9% | 120,000 | +20.0% | 0.13% | +27.0% |
| Q4 2017 | $4,638,000 | – | 100,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |